AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 27288835 — intervention group
Group type: EXPERIMENTAL
Intervention: Oxytocin
Number of subjects: 194
Study 26340941 — intervention group
Group type: EXPERIMENTAL
Intervention: Systematic cross-checkings between emergency physicians
Number of subjects: 1584
Study 26340941 — intervention group
Group type: COMPARATOR
Intervention: Usual care (control period)
Number of subjects: 1584
Study 24206639 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive remediation treatment (weekly group-based for 12 weeks)
Number of subjects: 40
Study 24206639 — intervention group
Group type: COMPARATOR
Intervention: Standard treatment alone
Number of subjects: 40
Study 24206639 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive remediation treatment
Number of subjects: 40
Study 21406514 — intervention group
Group type: EXPERIMENTAL
Intervention: Adaptive support ventilation (ASV)
Number of subjects: 97
Study 21406514 — intervention group
Group type: COMPARATOR
Intervention: Pressure support ventilation (PSV)
Number of subjects: 97
Study 19517247 — intervention group
Group type: EXPERIMENTAL
Intervention: Memantine at a dose of 20 mg/day
Number of subjects: 23
Study 19517247 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 23
Study 17222627 — intervention group
Group type: EXPERIMENTAL
Intervention: Prior radical prostatectomy
Number of subjects: 1238
Study 17222627 — intervention group
Group type: COMPARATOR
Intervention: No prior radical prostatectomy
Number of subjects: 1238
Study 15881107 — intervention group
Group type: EXPERIMENTAL
Intervention: Strepfen (flurbiprofen)
Number of subjects: 60
Study 15881107 — intervention group
Group type: COMPARATOR
Intervention: Paracetamol
Number of subjects: 60
Study 12469544 — intervention group
Group type: EXPERIMENTAL
Intervention: Multicomponent medication adherence intervention (behavioral strategies, simplified patient information, social support, cognitive‐behavioral therapy, nursing)
Number of subjects: 33
Study 12469544 — intervention group
Group type: EXPERIMENTAL
Intervention: Multicomponent medication adherence intervention
Number of subjects: 33
Study 12469544 — intervention group
Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 33
Study 9802635 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral tetravalent rotavirus vaccine (RV‐TV)
Number of subjects: 267
Study 9802635 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 267
Study 8575610 — intervention group
Group type: EXPERIMENTAL
Intervention: Fundus III oral liquid (10ml/time P.O. t.i.d. for 1 month)
Number of subjects: 80
Study 8575610 — intervention group
Group type: COMPARATOR
Intervention: Urokinase (10,000 u + 5% glucose 500ml/day i.v. drip for 5 days, followed by another 5 days)
Number of subjects: 80
Study 2197910 — intervention group
Group type: EXPERIMENTAL
Intervention: Inhaled pentamidine (8 mg/kg body weight)
Number of subjects: 21
Study 2197910 — intervention group
Group type: COMPARATOR
Intervention: Intravenous pentamidine (4 mg/kg body weight)
Number of subjects: 21
Study 2197910 — intervention group
Group type: EXPERIMENTAL
Intervention: Inhaled pentamidine
Number of subjects: 21
Study 92830 — intervention group
Group type: EXPERIMENTAL
Intervention: Neutron treatment (full course of 16 Gy)
Number of subjects: 59
Study 92830 — intervention group
Group type: EXPERIMENTAL
Intervention: Neutron treatment (reduced doses of 10 to 14 Gy)
Number of subjects: 59
Study 30539236 — intervention group
Group type: EXPERIMENTAL
Intervention: Drug-Coated Balloon (DCB) angioplasty
Number of subjects: 355
Study 30539236 — intervention group
Group type: COMPARATOR
Intervention: Plain Old Balloon Angioplasty (POBA)
Number of subjects: 355
Study 30539236 — intervention group
Group type: COMPARATOR
Intervention: Bailout stenting in POBA group
Number of subjects: 355
Study 28009692 — intervention group
Group type: EXPERIMENTAL
Intervention: 10,600 nm ablative fractional carbon dioxide (CO2) laser treatment (3 sessions)
Number of subjects: 9
Study 28009692 — intervention group
Group type: COMPARATOR
Intervention: Control (untreated half of the scar)
Number of subjects: 9
Study 25832340 — intervention group
Group type: EXPERIMENTAL
Intervention: High total flavonoid intake (total flavonoidUSDA)
Number of subjects: 1063
Study 25832340 — intervention group
Group type: EXPERIMENTAL
Intervention: High total flavonoid intake (total flavonoidPE)
Number of subjects: 1063
Study 24382970 — intervention group
Group type: EXPERIMENTAL
Intervention: CIK cell treatment
Number of subjects: 20
Study 24382970 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 20
Study 21804427 — intervention group
Group type: EXPERIMENTAL
Intervention: Abdominal exercise group (AG)
Number of subjects: 24
Study 21804427 — intervention group
Group type: COMPARATOR
Intervention: Control group (CG)
Number of subjects: 24
Study 19484630 — intervention group
Group type: EXPERIMENTAL
Intervention: Yoked prisms
Number of subjects: 30
Study 19484630 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 30
Study 16673014 — intervention group
Group type: EXPERIMENTAL
Intervention: Hydrochlorothiazide
Number of subjects: 70
Study 14676677 — intervention group
Group type: EXPERIMENTAL
Intervention: Cemented hip arthroplasty (Group 1)
Number of subjects: 35
Study 14676677 — intervention group
Group type: COMPARATOR
Intervention: Non-cemented hip arthroplasty (Group 2)
Number of subjects: 35
Study 10982571 — intervention group
Group type: EXPERIMENTAL
Intervention: TV anti-smoking advertising (TV media)
Number of subjects: 5468
Study 10982571 — intervention group
Group type: EXPERIMENTAL
Intervention: TV anti-smoking advertising plus locally organised anti-tobacco campaigning (TV media + LTCN)
Number of subjects: 5468
Study 10982571 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 5468
Study 10982571 — intervention group
Group type: EXPERIMENTAL
Intervention: TV media only and TV media + LTCN combined
Number of subjects: 5468
Study 8807183 — intervention group
Group type: EXPERIMENTAL
Intervention: PCORA (Patient Controlled Oral Analgesia)
Number of subjects: 20
Study 8807183 — intervention group
Group type: COMPARATOR
Intervention: CPPT (Customarily Prescribed Pain Therapy)
Number of subjects: 20
Study 8807183 — intervention group
Group type: EXPERIMENTAL
Intervention: PCORA
Number of subjects: 20
Study 8807183 — intervention group
Group type: COMPARATOR
Intervention: CPPT
Number of subjects: 20
Study 1679661 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous celiprolol (8 mg)
Number of subjects: 30
Study 1679661 — intervention group
Group type: EXPERIMENTAL
Intervention: Sublingual nifedipine (20 mg)
Number of subjects: 30
Study 1679661 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination therapy (celiprolol and nifedipine)
Number of subjects: 30
Study 1679661 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous celiprolol (8 mg) during exercise
Number of subjects: 30
Study 1679661 — intervention group
Group type: EXPERIMENTAL
Intervention: Sublingual nifedipine (20 mg) during exercise
Number of subjects: 30
Study 1679661 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination therapy during exercise
Number of subjects: 30
Study 6622436 — intervention group
Group type: EXPERIMENTAL
Intervention: 8-week group cholesterol reduction program (nonpharmacologic, behavioral education)
Number of subjects: 0
Study 6622436 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 0
Study 30514115 — intervention group
Group type: EXPERIMENTAL
Intervention: Group exercises (strength and aerobic exercises) performed twice a week for 24 weeks
Number of subjects: 52
Study 30514115 — intervention group
Group type: COMPARATOR
Intervention: Usual routine (control group)
Number of subjects: 52
Study 28245247 — intervention group
Group type: EXPERIMENTAL
Intervention: Decision support system (non-obtrusive, integrated in workflow)
Number of subjects: 781
Study 28245247 — intervention group
Group type: COMPARATOR
Intervention: Control group (no decision support system)
Number of subjects: 781
Study 26905112 — intervention group
Group type: EXPERIMENTAL
Intervention: Neo-adjuvant chemotherapy (5 fluorouracil, adriamycin, and cyclophosphamide) followed by modified radical mastectomy
Number of subjects: 31
Study 26905112 — intervention group
Group type: COMPARATOR
Intervention: Adjuvant chemotherapy after modified radical mastectomy
Number of subjects: 31
Study 24942155 — intervention group
Group type: EXPERIMENTAL
Intervention: Chronic low-dose recombinant human follicle-stimulating hormone (r-hFSH) protocol (starting daily dose: 75 IU, dose increase on Day 14)
Number of subjects: 247
Study 24942155 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-dose recombinant human follicle-stimulating hormone (r-hFSH) protocol (starting daily dose: 75 IU, dose increase on Day 7)
Number of subjects: 247
Study 22944480 — intervention group
Group type: EXPERIMENTAL
Intervention: Colposcopy
Number of subjects: 299
Study 20065991 — intervention group
Group type: EXPERIMENTAL
Intervention: Electrical stimulation (ES) superimposed on progressive resistance training (PRT)
Number of subjects: 20
Study 20065991 — intervention group
Group type: COMPARATOR
Intervention: No intervention (Control)
Number of subjects: 20
Study 18635497 — intervention group
Group type: EXPERIMENTAL
Intervention: Normal saline
Number of subjects: 90
Study 18635497 — intervention group
Group type: EXPERIMENTAL
Intervention: Lactated Ringer's
Number of subjects: 90
Study 18635497 — intervention group
Group type: EXPERIMENTAL
Intervention: Plasmalyte
Number of subjects: 90
Study 15884025 — intervention group
Group type: EXPERIMENTAL
Intervention: PRO‐SELF(c) Pain Control Program
Number of subjects: 0
Study 12039482 — intervention group
Group type: EXPERIMENTAL
Intervention: Primary coronary angioplasty
Number of subjects: 87
Study 12039482 — intervention group
Group type: COMPARATOR
Intervention: Intravenous (IV) streptokinase
Number of subjects: 87
Study 10627728 — intervention group
Group type: EXPERIMENTAL
Intervention: Increased levels of interleukin-6 in patients with total hip arthroplasty more than 10 years ago
Number of subjects: 0
Study 10627728 — intervention group
Group type: COMPARATOR
Intervention: Control subjects without total hip arthroplasty
Number of subjects: 0
Study 10627728 — intervention group
Group type: COMPARATOR
Intervention: Patients with a prosthesis in place for less than 6 years
Number of subjects: 0
Study 8749332 — intervention group
Group type: EXPERIMENTAL
Intervention: Rigid contact lenses
Number of subjects: 32
Study 8749332 — intervention group
Group type: COMPARATOR
Intervention: Soft contact lenses
Number of subjects: 32
Study 2537560 — intervention group
Group type: EXPERIMENTAL
Intervention: Lisinopril
Number of subjects: 130
Study 2537560 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 130
Study 781231 — intervention group
Group type: EXPERIMENTAL
Intervention: Fenoprofen (2.4 gm/day)
Number of subjects: 216
Study 781231 — intervention group
Group type: COMPARATOR
Intervention: Aspirin (3.9 gm/day)
Number of subjects: 216
Study 31511862 — intervention group
Group type: EXPERIMENTAL
Intervention: Paclitaxel-coated balloon (PCB)
Number of subjects: 1976
Study 31511862 — intervention group
Group type: COMPARATOR
Intervention: Drug-eluting stent (DES)
Number of subjects: 1976
Study 30904879 — intervention group
Group type: EXPERIMENTAL
Intervention: Manipulation and surgical fixation with K‐wires
Number of subjects: 0
Study 30904879 — intervention group
Group type: COMPARATOR
Intervention: Manipulation and plaster casting
Number of subjects: 0
Study 28258582 — intervention group
Group type: EXPERIMENTAL
Intervention: Cesarean delivery
Number of subjects: 2791
Study 28258582 — intervention group
Group type: COMPARATOR
Intervention: Vaginal delivery
Number of subjects: 2791
Study 26382562 — intervention group
Group type: EXPERIMENTAL
Intervention: Diode laser adjunct treatment (1.0 W power, pulsed mode, λ 810 nm, energy density 3 J/cm², time 1 min, power density 400 mW/cm², energy 1.5 J, spot diameter 1 mm)
Number of subjects: 10
Study 26382562 — intervention group
Group type: COMPARATOR
Intervention: Conventional scaling and debridement (control group)
Number of subjects: 10
Study 26382562 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (laser and control)
Number of subjects: 10
Study 23414253 — intervention group
Group type: EXPERIMENTAL
Intervention: SBP + BAI
Number of subjects: 252
Study 23414253 — intervention group
Group type: COMPARATOR
Intervention: SBP
Number of subjects: 252
Study 20438562 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 80
Study 20438562 — intervention group
Group type: EXPERIMENTAL
Intervention: Sildenafil (50 mg)
Number of subjects: 80
Study 20438562 — intervention group
Group type: EXPERIMENTAL
Intervention: Tadalafil (20 mg)
Number of subjects: 80
Study 20438562 — intervention group
Group type: EXPERIMENTAL
Intervention: Vardenafil (10 mg)
Number of subjects: 80
Study 19198647 — intervention group
Group type: COMPARATOR
Intervention: Control: energy intake at 100% of energy requirements
Number of subjects: 48
Study 19198647 — intervention group
Group type: EXPERIMENTAL
Intervention: CR: 25% calorie restriction
Number of subjects: 48
Study 19198647 — intervention group
Group type: EXPERIMENTAL
Intervention: CR+EX: 12.5% CR plus 12.5% increase in energy expenditure by structured exercise
Number of subjects: 48
Study 19198647 — intervention group
Group type: EXPERIMENTAL
Intervention: LCD: low calorie diet (890 kcal/d) until 15% weight reduction followed by weight maintenance
Number of subjects: 48
Study 22373499 — intervention group
Group type: EXPERIMENTAL
Intervention: Feedback group
Number of subjects: 54
Study 22373499 — intervention group
Group type: COMPARATOR
Intervention: No feedback group
Number of subjects: 54
Study 15988144 — intervention group
Group type: EXPERIMENTAL
Intervention: Radiation-associated AML
Number of subjects: 53
Study 15988144 — intervention group
Group type: COMPARATOR
Intervention: Spontaneous AML (Control)
Number of subjects: 53
Study 15988144 — intervention group
Group type: EXPERIMENTAL
Intervention: Radiation exposure
Number of subjects: 53
Study 15988144 — intervention group
Group type: EXPERIMENTAL
Intervention: Age stratification
Number of subjects: 53
Study 15988144 — intervention group
Group type: EXPERIMENTAL
Intervention: MDS following radiation exposure
Number of subjects: 53
Study 12882773 — intervention group
Group type: EXPERIMENTAL
Intervention: Best corrected logMAR visual acuity measured at baseline and 1 month later using ETDRS logMAR charts.
Number of subjects: 86
Study 9619885 — intervention group
Group type: EXPERIMENTAL
Intervention: Rheumatoid Arthritis leaflet
Number of subjects: 84
Study 9619885 — intervention group
Group type: COMPARATOR
Intervention: Control group (no leaflet)
Number of subjects: 84
Study 7642848 — intervention group
Group type: COMPARATOR
Intervention: Angina-guided strategy (n = 183)
Number of subjects: 558
Study 7642848 — intervention group
Group type: COMPARATOR
Intervention: Ischemia-guided strategy (n = 183)
Number of subjects: 558
Study 7642848 — intervention group
Group type: EXPERIMENTAL
Intervention: Revascularization strategy (n = 192)
Number of subjects: 558
Study 7642848 — intervention group
Group type: COMPARATOR
Intervention: Angina-guided strategy
Number of subjects: 558
Study 7642848 — intervention group
Group type: COMPARATOR
Intervention: Ischemia-guided strategy
Number of subjects: 558
Study 7642848 — intervention group
Group type: EXPERIMENTAL
Intervention: Revascularization strategy
Number of subjects: 558
Study 2505642 — intervention group
Group type: EXPERIMENTAL
Intervention: Atropine 10 micrograms/kg
Number of subjects: 24
Study 2505642 — intervention group
Group type: EXPERIMENTAL
Intervention: Glycopyrrolate 5 micrograms/kg
Number of subjects: 24
Study 2505642 — intervention group
Group type: COMPARATOR
Intervention: 0.9% sodium chloride (saline)
Number of subjects: 24
Study 1070220 — intervention group
Group type: EXPERIMENTAL
Intervention: Elema 588 B electrodes
Number of subjects: 159
Study 1070220 — intervention group
Group type: COMPARATOR
Intervention: Chardack 5818 electrodes
Number of subjects: 159
Study 1070220 — intervention group
Group type: EXPERIMENTAL
Intervention: Patients with heart disease
Number of subjects: 159
Study 12185398 — intervention group
Group type: EXPERIMENTAL
Intervention: Diazepam (15 mg)
Number of subjects: 45
Study 12185398 — intervention group
Group type: EXPERIMENTAL
Intervention: Metoprolol (50 mg)
Number of subjects: 45
Study 12185398 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 45
Study 31012564 — intervention group
Group type: EXPERIMENTAL
Intervention: Calcipotriene-Betamethasone Dipropionate Aerosol Foam (Calcipotriene 0.005% and Betamethasone Dipropionate 0.064%)
Number of subjects: 0
Study 31012564 — intervention group
Group type: EXPERIMENTAL
Intervention: Calcipotriene-Betamethasone Dipropionate Aerosol Foam
Number of subjects: 0
Study 31012564 — intervention group
Group type: COMPARATOR
Intervention: Vehicle (Control)
Number of subjects: 0
Study 28639445 — intervention group
Group type: EXPERIMENTAL
Intervention: PRO group (periodized training)
Number of subjects: 30
Study 28639445 — intervention group
Group type: EXPERIMENTAL
Intervention: FRE group (free training)
Number of subjects: 30
Study 28639445 — intervention group
Group type: COMPARATOR
Intervention: UNI group (uniform training)
Number of subjects: 30
Study 27863602 — intervention group
Group type: EXPERIMENTAL
Intervention: Fordyce Happiness Model (FHM)
Number of subjects: 140
Study 27863602 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 140
Study 25046945 — intervention group
Group type: EXPERIMENTAL
Intervention: Chinese Compound Shenhuang Ointment (CSO)
Number of subjects: 220
Study 23217267 — intervention group
Group type: EXPERIMENTAL
Intervention: Biphasic insulin aspart 30 (BIAsp30)
Number of subjects: 6323
Study 23217267 — intervention group
Group type: EXPERIMENTAL
Intervention: BIAsp30
Number of subjects: 6323
Study 20460999 — intervention group
Group type: EXPERIMENTAL
Intervention: Ropivacaine 0.5% (30 ml)
Number of subjects: 103
Study 20460999 — intervention group
Group type: COMPARATOR
Intervention: Ropivacaine 0.375% (20 ml)
Number of subjects: 103
Study 20460999 — intervention group
Group type: EXPERIMENTAL
Intervention: Ropivacaine concentration increase
Number of subjects: 103
Study 20460999 — intervention group
Group type: EXPERIMENTAL
Intervention: Ropivacaine 0.5% (ED(volume)50/ED(volume)95)
Number of subjects: 103
Study 20460999 — intervention group
Group type: EXPERIMENTAL
Intervention: Ropivacaine 20 ml (ED(concentration)50/ED(concentration)95)
Number of subjects: 103
Study 20460999 — intervention group
Group type: EXPERIMENTAL
Intervention: Ropivacaine doses
Number of subjects: 103
Study 18723862 — intervention group
Group type: EXPERIMENTAL
Intervention: Home-based rehabilitation programme
Number of subjects: 229
Study 18723862 — intervention group
Group type: COMPARATOR
Intervention: Day rehabilitation programme
Number of subjects: 229
Study 16378790 — intervention group
Group type: EXPERIMENTAL
Intervention: Electronic educational detailing
Number of subjects: 884
Study 16378790 — intervention group
Group type: EXPERIMENTAL
Intervention: Direct (face‐to‐face) educational detailing
Number of subjects: 884
Study 16378790 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of electronic and direct detailing
Number of subjects: 884
Study 16378790 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 884
Study 16378790 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall intervention
Number of subjects: 884
Study 12381335 — intervention group
Group type: EXPERIMENTAL
Intervention: Deltatrac calorimeter with disposable standard‐bore air tube and filter
Number of subjects: 11
Study 12381335 — intervention group
Group type: COMPARATOR
Intervention: Deltatrac calorimeter with standard wide‐bore tubing
Number of subjects: 11
Study 12381335 — intervention group
Group type: EXPERIMENTAL
Intervention: Both methods
Number of subjects: 11
Study 9527978 — intervention group
Group type: EXPERIMENTAL
Intervention: OMC (omeprazole 20 mg b.i.d., metronidazole 500 mg b.i.d., clarithromycin 500 mg b.i.d.)
Number of subjects: 88
Study 9527978 — intervention group
Group type: COMPARATOR
Intervention: OMA (omeprazole 20 mg b.i.d., metronidazole 500 mg b.i.d., amoxycillin 1 g b.i.d.)
Number of subjects: 88
Study 9527978 — intervention group
Group type: EXPERIMENTAL
Intervention: OMC
Number of subjects: 88
Study 9527978 — intervention group
Group type: COMPARATOR
Intervention: OMA
Number of subjects: 88
Study 9527978 — intervention group
Group type: EXPERIMENTAL
Intervention: Eradication of H. pylori
Number of subjects: 88
Study 7639092 — intervention group
Group type: EXPERIMENTAL
Intervention: Citalopram (20-60 mg/day)
Number of subjects: 15
Study 7639092 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 15
Study 2702968 — intervention group
Group type: EXPERIMENTAL
Intervention: Felodipine 5 mg
Number of subjects: 15
Study 2702968 — intervention group
Group type: EXPERIMENTAL
Intervention: Felodipine 10 mg
Number of subjects: 15
Study 2702968 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 15
Study 911706 — intervention group
Group type: EXPERIMENTAL
Intervention: Iron supplements
Number of subjects: 64
Study 911706 — intervention group
Group type: EXPERIMENTAL
Intervention: Iron+folate supplements
Number of subjects: 64
Study 911706 — intervention group
Group type: COMPARATOR
Intervention: Inactive placebo
Number of subjects: 64
Study 911706 — intervention group
Group type: EXPERIMENTAL
Intervention: Nineteen women not included in the trial
Number of subjects: 64
Study 31476826 — intervention group
Group type: EXPERIMENTAL
Intervention: Targeted SMS reminders
Number of subjects: 138
Study 31476826 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 138
Study 28657655 — intervention group
Group type: EXPERIMENTAL
Intervention: Nail polish (P)
Number of subjects: 21
Study 28657655 — intervention group
Group type: COMPARATOR
Intervention: Nonpolished (NP) fingernails (C)
Number of subjects: 21
Study 26549589 — intervention group
Group type: EXPERIMENTAL
Intervention: sorafenib (400 mg twice daily)
Number of subjects: 267
Study 26549589 — intervention group
Group type: COMPARATOR
Intervention: placebo
Number of subjects: 267
Study 26549589 — intervention group
Group type: EXPERIMENTAL
Intervention: sorafenib
Number of subjects: 267
Study 23929659 — intervention group
Group type: EXPERIMENTAL
Intervention: Darexaban 20 mg
Number of subjects: 82
Study 23929659 — intervention group
Group type: EXPERIMENTAL
Intervention: Darexaban 60 mg
Number of subjects: 82
Study 23929659 — intervention group
Group type: EXPERIMENTAL
Intervention: Darexaban 120 mg
Number of subjects: 82
Study 23929659 — intervention group
Group type: EXPERIMENTAL
Intervention: Darexaban 240 mg
Number of subjects: 82
Study 23929659 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 82
Study 21248382 — intervention group
Group type: EXPERIMENTAL
Intervention: Functional electrical stimulation using a generalized transfer function that maps EMG activity into a stimulation pattern.
Number of subjects: 0